Latest News & Updates
Breaking News
11 hours ago
Simantini Singh Deo
Other trending news you may like to read
Rigel Pharmaceuticals Secures VEPPANU License from Arvinas and Pfizer Ahead of August Commercial Launch
Rigel closes $70M VEPPANU license with Arvinas and Pfizer, targeting August commercial launch for the FDA-approved ESR1-mutated breast cancer therapy.
Simantini Singh Deo
Vertex Pharmaceuticals Gains Updated FDA Approval Letter for CASGEVY Gene Therapy in SCD and TDT
FDA issues a June 2026 approval letter for Vertex's CASGEVY under STN 125787, extending the post-approval compliance record for this CRISPR-based gene therapy.
Simantini Singh Deo
Horphag Research Positions Pycnogenol as Multifunctional Core Ingredient for Women's Health Formulations
Horphag Research advances Pycnogenol® as a multi-claim women's health ingredient backed by 160+ clinical studies across skin, menopause, circulation, and joints.
Vaibhavi M.
Koi Peptides Launches BPC-157 and TB-500 Research Blend with Per-Lot Certificate of Analysis
Koi Peptides releases a lyophilized BPC-157/TB-500 research blend with per-lot CoA documentation for laboratory traceability.
Vaibhavi M.
